USE OF A HEXANO-ETHYL ACETATE EXTRACT OF AGERATINA PICHINCHENSIS FOR THE TREATMENT OF DIABETIC FOOT ULCERS.

摘要

The present disclosure is related to the use of an aqueous extract and/or organic of Ageratina pichinchensis standardized by the content of the active principle, 7-O-(ß-D-glucopyranosyl)- galectin in the manufacturing of a pharmaceutical composition useful in the treatment of ulcers in patients with poor or impaired wound healing processes, such as when occurs in patients with ulcers caused by peripheral circulatory complications from diabetes mellitus.